Some people fail to see the obvious ..
" The objective of the meeting was to seek guidance on the plans for further development of BNC210 in a second Phase 2 trial in PTSD patients using the newly developed tablet formulation and aiming for the exposure levels predicted from the pharmacometric analyses to have potential for clinical benefit."
There is a different tablet formulation-larger dose and slow release-animal models already were demonstrating the benefit of BNC210.
The potential for SP rise is very clear. The CR will happen but the circumstances will be improved.
- Forums
- ASX - By Stock
- BNO
- Capital Raising is coming - adopt the brace position
Capital Raising is coming - adopt the brace position, page-34
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BNO (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online